𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Interferon-β-1b study spells bad news for patients with MS?

Book ID
120869716
Publisher
Adis International Limited (now part of Wolters Kluwer Health)
Year
2000
Weight
143 KB
Volume
&NA;
Category
Article
ISSN
1173-8324

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Extended observations on MS patients tre
Extended observations on MS patients treated with IM interferon-β1a (Avonex™): implications for modern MS trials and therapeutics
✍ Lawrence Jacobs; Richard Rudick; Jack Simon 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 82 KB

Extended observations of the pivotal phase III clinical trial of interferon-beta1a (IFNbeta1a; Avonex, Biogen) in relapsing MS patients revealed that: (1) active treatment significantly slowed the accumulation of physical disability over time, reduced clinical exacerbations and MRI brain lesions; (2